✦ LIBER ✦

424 Durability of HBEAG seroconversion after adefovir dipivoxil treatment for chronic hepatitis B (CHB)

✍ Scribed by T.T. Chang; M. Shiffman; M. Tong; P. Marcellin; Y.F. Liaw; P. Luengrojanakul; G.S. Choy; C. James; J. Ma; S. Xiong; G. Currie; C.L. Brosgart

Book ID: 117373253
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 63 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(04)90424-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

503 Durability of HBeAg seroconversion f

503 Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)

✍ T.T. Chang; M.L. Shiffman; M. Tong; Y.E. Liaw; P. Komolmit; J. Sorbel; S. Arterb 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

P.104 Durability of HBeAg seroconversion

P.104 Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)

✍ T.T. Chang; M.L. Shiffman; M. Tong; Y.F. Liaw; P. Komolmit; J. Sorbel; S. Arterb 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

18 OUTCOME OF HBeAg-NEGATIVE CHRONIC HEP

18 OUTCOME OF HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHB) 5 YEARS AFTER DISCONTINUATION OF LONG TERM ADEFOVIR DIPIVOXIL (ADV) TREATMENT

✍ S. Hadziyannis; V. Sevastianos; I. Rapti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Resistance surveillance of HBEAG— chroni

Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)

✍ S. Xiong; H. Yang; C.E. Westland; W.E. Delaney IV; D. Colledge; A. Bartholomeusz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

706 SUSTAINED DURABILITY OF HBEAG SEROCO

706 SUSTAINED DURABILITY OF HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B PATIENTS AFTER TREATMENT WITH TELBIVUDINE

✍ T. Poynard; J.-L. Hou; A. Chutaputti; M. Manns; N. Naoumov 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

OL-047 Long-term therapy with adefovir d

OL-047 Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment

✍ J. You; L. Zhuang; H.Y. Chen; X. Feng; L. Kong; H. Lei; Y.L. Ma; Y.L. Li; W.B. Y 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB